Alpha Cognition Inc (NASDAQ: ACOG) is a Healthcare company (Biotechnology) with a market capitalization of $123M. The Maz Rating grades it against the other companies in its sector.
Alpha Cognition Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $7.92, Alpha Cognition Inc trades at 6.1x sales and 3.5x book value. Over the last twelve months it generated about $20M of revenue and a net loss of $21M. It runs a gross margin of 93.1%, an operating margin of -149.6% and a net margin of -147.3%. It shows return on equity of -53.5%, return on invested capital of -54.0% and a free cash flow yield of -25.2%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 7.13. Over the past 52 weeks the share price ranged from $4.50 to $10.14, with a beta of 2.33.
Alpha Cognition Inc does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Alpha Cognition Inc (ACOG) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 19.6% / 30% · Interest income / Revenue 4.60% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 19.6% / 33% · Receivables / Mkt Cap (36m) 3.63% / 49% · Interest income / Revenue 4.60% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 19.6% / 33.33% · Receivables / Mkt Cap (24m) 3.63% / 33.33% · Interest income / Revenue 4.60% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.00% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 71.9% / 33.33% · Receivables / Avg Assets (4Q) 7.31% / 33.33% · Interest income / Revenue 4.60% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 59.1% / 33.33% · (Cash+Recv) / Total Assets 70.0% / 33.33% · Interest income / Revenue 4.60% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Alpha Cognition Inc (ACOG) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Alpha Cognition Inc is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 4.60% of each dividend: Alpha Cognition Inc's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.